Psilocybin, the key psychoactive compound in magic mushrooms, remains to be a federally-managed Program I drug; that means that psilocybin mushrooms are deemed to acquire no medically acknowledged use and carry a superior opportunity for abuse. But FDA-permitted trials to the selected breakthrough therapy continue just after scientific studies foun